Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
Initial data expected in the first half of 2027 Initial data expected in the first half of 2027
Initial data expected in the first half of 2027 Initial data expected in the first half of 2027